The transcription factor E2F1 and the SR protein SC35 control the ratio of pro-angiogenic versus antiangiogenic isoforms of vascular endothelial growth factor-A to inhibit neovascularization in vivo (Q39678637)
Jump to navigation
Jump to search
scientific article published on 19 July 2010
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | The transcription factor E2F1 and the SR protein SC35 control the ratio of pro-angiogenic versus antiangiogenic isoforms of vascular endothelial growth factor-A to inhibit neovascularization in vivo |
scientific article published on 19 July 2010 |
Statements
1 reference
The transcription factor E2F1 and the SR protein SC35 control the ratio of pro-angiogenic versus antiangiogenic isoforms of vascular endothelial growth factor-A to inhibit neovascularization in vivo (English)
1 reference
G Merdzhanova
1 reference
S Gout
1 reference
M Keramidas
1 reference
V Edmond
1 reference
J-L Coll
1 reference
C Brambilla
1 reference
E Brambilla
1 reference
S Gazzeri
1 reference
B Eymin
1 reference
19 July 2010
1 reference
1 reference
29
1 reference
39
1 reference
5392-5403
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference
1 reference